Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Transaminases

Known as: Aminotransferases, Aminotransferase, Transaminase 
Transaminases are a sub-subclass of mostly pyridoxal phosphate-dependent transferase enzymes that catalyze the transfer of an amino group from a… Expand
National Institutes of Health

Related topics

Related topics

49 relations

Narrower (38)

4-Aminobutyrate aminotransferase7,8-diaminopelargonic acid aminotransferase7,8-diaminoperlargonic acid aminotransferase, Mycobacterium tuberculosisAGD2-LIKE DEFENSE RESPONSE PROTEIN1, Arabidopsis
Expand
BCAT1 geneEnzyme GeneIn BloodProcess of secretion
Expand

Broader (2)

Nitrogenous Group TransferasesTransferase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic Brain
Glutamate is present in the brain at an average concentration—typically 10–12 mM—far in excess of those of other amino acids. In… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2013
Highly Cited
2013
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
BACKGROUND In single-group studies, chromosomal rearrangements of the anaplastic lymphoma kinase gene (ALK) have been associated… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2011
Highly Cited
2011
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase…
BACKGROUND Activating mutations in EGFR are important markers of response to tyrosine kinase inhibitor (TKI) therapy in non-small… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2010
Highly Cited
2010
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
BACKGROUND Non-small-cell lung cancer with sensitive mutations of the epidermal growth factor receptor (EGFR) is highly… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2004
Highly Cited
2004
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
Despite the increasing prevalence of nonalcoholic fatty liver disease (NAFLD), its pathogenesis and clinical significance remain… Expand
Highly Cited
2003
Highly Cited
2003
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
Information on the stage of liver fibrosis is essential in managing chronic hepatitis C (CHC) patients. However, most models for… Expand
Highly Cited
1998
Highly Cited
1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
BACKGROUND Only 15 to 20 percent of patients with chronic hepatitis C have a sustained virologic response to interferon therapy… Expand
Review
1994
Review
1994
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
We have developed a conceptual framework and a set of research guidelines for use in studies of the chronic fatigue syndrome. The… Expand
Highly Cited
1957
Highly Cited
1957
A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.
Highly Cited
1955
Highly Cited
1955
Transaminase activity in human blood.
Enzymatic transamination consists of the enzyme catalyzed reversible transfer of the alpha amino nitrogen of an amino acid to an… Expand
  • table I
  • figure 2
  • figure 1
  • table I
  • table III
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE